Abstract / Manuscript

Resources and insights tagged abstract manuscript from Pedestal Health.

Total Publications

Abstract/Manuscript

2025 · Abstract/Manuscript · UNC

The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH

2025 · Abstract/Manuscript · Kings College of London

Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease

2025 · Abstract/Manuscript

DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy

2025 · Abstract/Manuscript · Northwestern University

Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry

2025 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

2024 · Abstract/Manuscript · Duke

Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort

2024 · Abstract/Manuscript · Heinrich Heine University Dusseldorf/German Diabetes Center

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort

2024 · Abstract/Manuscript · Northwestern University

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry

2024 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

2024 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Use of tenofovir-based PrEP among pregnant women in South Africa

2024 · Abstract/Manuscript · University of Alabama at Birmingham

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

2024 · Abstract/Manuscript

Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry

2023 · Abstract/Manuscript

Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry (2023 abstract)

2023 · Abstract/Manuscript · National University Hospital

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort

2023 · Abstract/Manuscript · Mayo Clinic

Impact of itch on quality of life in people with primary biliary cholangitis: a plain language summary

2023 · Abstract/Manuscript · Northwestern University

Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort

2023 · Abstract/Manuscript · UCSD

Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

2023 · Abstract/Manuscript · University of North Carolina at Chapel Hill

When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

2023 · Abstract/Manuscript · Harvard T.H. Chan School of Public Health

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study

2022 · Abstract/Manuscript · Emory

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

2022 · Abstract/Manuscript · Mayo Clinic

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

2022 · Abstract/Manuscript · Northwestern University

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort

2022 · Abstract/Manuscript · Atrium Health

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

2022 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Postpartum Medicaid enrollment and churn in North Carolina

2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf

Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis

2021 · Abstract/Manuscript · Heinrich Heine University Düsseldorf

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

2021 · Abstract/Manuscript · University of Michigan

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study

2021 · Abstract/Manuscript · University of Michigan

Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort

2021 · Abstract/Manuscript · Zucker School of Medicine at Hofstra

Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV

2021 · Abstract/Manuscript · Atrium Health

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease

2021 · Abstract/Manuscript · University of Chicago

Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD

2021 · Abstract/Manuscript · Amgen Inc.

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018

2021 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Factors Associated with Readmission in the US Following Hospitalization with COVID-19

2020 · Abstract/Manuscript · University of Michigan

Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease

2020 · Abstract/Manuscript · University of Michigan

Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases

2020 · Abstract/Manuscript · University of Michigan

A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

2020 · Abstract/Manuscript · Amgen Inc.

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

2020 · Abstract/Manuscript · University of Alabama at Birmingham

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

2020 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States

2018 · Abstract/Manuscript

A Real-World Observational Cohort of Patients with Primary Biliary Cholangitis: TARGET-PBC Study Design and Rationale

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

2018 · Abstract/Manuscript · University of North Carolina at Chapel Hill

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

2017 · Abstract/Manuscript · Emory

Abstract / Manuscript

The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASH

Cardiovascular risk assessment tools are insufficient for patients with metabolic dysfunction associated steatotic liver disease

DAA-PASS: A Prospective Evaluation of HCC Recurrence After Direct Acting Antiviral Therapy

Unmet Needs of Effective Advanced Systemic Therapies in Moderate-to-Severe Atopic Dermatitis Patients in the TARGET-DERM AD Registry

Leveraging public health infrastructures to support sexual health for women living in the Southern United States

Concordance of MASLD and NAFLD nomenclature in youth participating in the TARGET-NASH real-world cohort

High Concordance Between Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease in the TARGET-NASH Real-World Cohort

Real-world evidence on the benefits of optimal itch relief and skin clearance in atopic dermatitis management: a study from the TARGET-DERM AD registry

Factors Predicting Loss of Remission in Crohn's Disease Patients in Endoscopic Remission in the Real World Results From TARGET-IBD

Use of tenofovir-based PrEP among pregnant women in South Africa

Comparing PCSK9 Monoclonal Antibody Treatment Strategies Following Myocardial Infarction Using Negative Control Outcomes: A Target Trial Emulation Study

Use of Advanced Systemic Therapy in Patients with Moderate to Severe Atopic Dermatitis in the TARGET-DERM Registry

Healthcare Disparities in Atopic Dermatitis: Insights from TARGET DERM Registry (2023 abstract)

Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort

Impact of itch on quality of life in people with primary biliary cholangitis: a plain language summary

Prevalence and burden of atopic dermatitis involving the head, neck, face, and hand: A cross sectional study from the TARGET-DERM AD cohort

Do Atopic Dermatitis Patient-Reported Outcomes Correlate With Validated Investigator Global Assessment? Insights From TARGET-AD Registry

Prevalence of Immunomodulator Use as Combination Therapy With Vedolizumab or Ustekinumab in Inflammatory Bowel Disease

Evaluation of a Natural Language Processing Model to Identify and Characterize Patients in the United States With High-Risk Non–Muscle-Invasive Bladder Cancer

Effectiveness of Remdesivir Treatment Protocols Among Patients Hospitalized with COVID-19: A Target Trial Emulation

When Emulating a Trial, Do as the Trialists Do: Missteps in Estimating Relative Effectiveness of a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Booster Dose

Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women

High PrEP uptake and objective longitudinal adherence among HIV-exposed women with personal or partner plans for pregnancy in rural Uganda: A cohort study

Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis

Real-world evidence on atopic dermatitis: Baseline characteristics and predictors of treatment choice in the TARGET cohort

Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

Postpartum Medicaid enrollment and churn in North Carolina

Liver Biopsy in the Real World—Reporting, Expert Concordance and Correlation with a Pragmatic Clinical Diagnosis

Prevalence and Factors Associated With Statin Use Among Patients With Nonalcoholic Fatty Liver Disease in the TARGET-NASH Study

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET-NASH Study

Weight Loss and Weight Regain in Usual Clinical Practice: Results from the TARGET-NASH Observational Cohort

Safety and Effectiveness of Tenofovir Alafenamide in Usual Clinical Practice Confirms Results of Clinical Trials: TARGET-HBV

Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease

Methodology and initial results from a real-world observational cohort of patients with inflammatory bowel disease: TARGET-IBD

Effectiveness and Safety of Romiplostim Among Patients with Newly Diagnosed, Persistent and Chronic Immune Thrombocytopenia in European Clinical Practice

Medicaid Coverage Disruptions Among Children Enrolled in North Carolina Medicaid From 2016 to 2018

Factors Associated with Readmission in the US Following Hospitalization with COVID-19

Opioid Use is More Common in Non-Alcoholic Fatty Liver Disease Patients with Cirrhosis, Higher Body Mass Index and Psychiatric Disease

Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Co-morbid Diseases

A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States

Lipid Testing Trends in the US Before and After the Release of the 2013 Cholesterol Treatment Guidelines

Patient Characteristics and Outcomes of 11,721 Patients with COVID19 Hospitalized Across the United States

A Real-World Observational Cohort of Patients with Primary Biliary Cholangitis: TARGET-PBC Study Design and Rationale

Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States

Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US

Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: the TARGET-NASH study